NEUROCRINE BIOSCIENCES, INC. (NBIX) Operating income 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) annual operating income history from SEC filings — each fiscal year as reported.
$619.1MFY2025 · since FY2016: -$147.4M → $619.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $619.1M | +8.5% |
| FY2024 | $570.5M | +127.4% |
| FY2023 | $250.9M | +0.8% |
| FY2022 | $249.0M | +142.9% |
| FY2021 | $102.5M | -37.1% |
| FY2020 | $163.0M | +125.4% |
| FY2019 | $72.3M | +96.5% |
| FY2018 | $36.8M | +128.0% |
| FY2017 | -$131.4M | +10.9% |
| FY2016 | -$147.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice